✦ LIBER ✦

Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma

✍ Scribed by Nozomi Niitsu; Masataka Okamoto; Sadao Aoki; Hirokazu Okumura; Tadashi Yoshino; Ikuo Miura; Masami Hirano

Publisher: Springer
Year: 2006
Tongue: English
Weight: 123 KB
Volume: 85
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-006-0080-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II study of CyclOBEAP

Multicenter phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma

✍ Nozomi Niitsu; Masataka Okamoto; Mika Kohori; Sadao Aoki; Ikuo Miura; Masami Hir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

## Abstract We treated elderly patients (65–69 years) who had aggressive lymphoma with the CyclOBEAP regimen, and we studied the safety and efficacy of this treatment. The CyclOBEAP regimen was administered over a total period of 12 weeks. Doxorubicin 40 mg/m^2^ was given every 2 weeks in combinati

Four versus six courses of a dose-escala

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation : Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma

✍ Nobert Schmitz; Marita Kloess; Marcel Reiser; Wolfgang E. Berdel; Bernd Metzner; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB